INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

1,241 studies · page 20 of 52

2010 / Network of multicentric case-control studies

Higher intakes of various flavonoids and proanthocyanidins were linked to lower risks of several common cancers in an Italian case-control network.

Researchers analyzed intakes of six classes of flavonoids and proanthocyanidins among approximately 10,000 cancer cases and over 16,000 controls across Italian case-control studies. Comparing the highest to lowest quintiles, total flavonoids, flavanones, and flavonols were inversely associated with oral (ORs 0.56, 0.51, and 0.62) and laryngeal cancers (ORs 0.60, 0.60, and 0.32). Colorectal cancer risk was reduced for high intakes of anthocyanidins (OR = 0.67), flavonols (OR = 0.64), flavones (OR = 0.78), isoflavones (OR = 0.76), and proanthocyanidins (OR = 0.69 for ≥10 mers). Inverse associations were also observed for breast, ovarian, and renal cancers with specific flavonoid classes, but no association emerged for prostate cancer.

Shows an association, not proof of cause and effect.

Rossi M, Bosetti C, Negri E, et al. Nutr Cancer, 2010. PMID 20924962

2010 / Prospective cohort study

High soy isoflavone intake was linked to a lower risk of breast cancer recurrence in postmenopausal patients on adjuvant endocrine therapy.

Researchers examined associations between baseline dietary intake of soy isoflavones, assessed via a food frequency questionnaire, and breast cancer recurrence and death among 524 patients over a median follow-up of 5.1 years. Among premenopausal patients, overall death rate was not related to soy isoflavone intake (HR 1.05, 95% CI 0.78-1.71 for >42.3 mg/day vs. <15.2 mg/day, p for trend = 0.87). In postmenopausal patients, the highest quartile of intake had a significantly lower risk of recurrence compared to the lowest quartile (HR 0.67, 95% CI 0.54-0.85, p for trend = 0.02), with inverse associations observed in estrogen and progesterone receptor-positive patients and those receiving anastrozole.

Shows an association, not proof of cause and effect.

Kang X, Zhang Q, Wang S, et al. CMAJ, 2010. PMID 20956506

2010 / Prospective case-cohort study

In Dutch men, having 1-2 bowel movements daily was linked to higher rectal cancer risk, while frequent constipation was linked to lower risk.

Researchers analyzed associations between bowel movement and constipation frequencies and colorectal cancer endpoints over 13.3 years among men in the Netherlands Cohort Study on Diet and Cancer. Having 1-2 bowel movements per day compared with once a day was associated with higher risks of overall CRC (HR = 1.29, 95% CI: 1.09, 1.53) and rectal cancer (HR = 1.50, 95% CI: 1.15, 1.95). Conversely, reporting constipation sometimes or more often versus never was linked to lower risks of overall CRC (HR = 0.76, 95% CI: 0.58, 0.98) and rectal cancer (HR = 0.57, 95% CI: 0.35, 0.90). No trends were found for proximal or distal colon cancer risk, and interactions with dietary fiber intake were not significant.

Shows an association, not proof of cause and effect.

Simons CC, Schouten LJ, Weijenberg MP, et al. Am J Epidemiol, 2010. PMID 20980354

2010 / Two case-control studies

Higher urinary cadmium levels were associated with increased odds of breast cancer in US and Long Island women.

Researchers evaluated the link between urinary cadmium (UCd) and breast cancer in a Long Island, NY case-control sample and a representative US sample from NHANES (1999-2008). In multivariable logistic models, both groups displayed a significant trend for increased odds of breast cancer across increasing UCd quartiles (NHANES p=0.039; Long Island p=0.023). Long Island women in the highest versus lowest quartile had higher breast cancer odds (OR=2.69; 95% CI=1.07, 6.78). In the NHANES cohort, women in the two highest quartiles also had increased risk (OR=2.50; 95% CI=1.11, 5.63 and OR=2.22; 95% CI=0.89, 5.52, respectively).

Shows an association, not proof of cause and effect.

Gallagher CM, Chen JJ, Kovach JS Aging (Albany NY), 2010. PMID 21071816

2010 / Observational study

In Norway, cancer prognosis was significantly better when diagnosis occurred in summer or autumn compared to winter or spring.

Researchers analyzed seasonal patterns of cancer incidence, death rates, and prognosis in Norway. They found no consistent, significant seasonal variation in incidence or death rates for internal cancers. However, there was a significant seasonal variation in cancer prognosis based on season of diagnosis, with the best prognosis observed for summer and autumn diagnoses. The authors note this aligns with seasons of peak vitamin D status in the population.

Shows an association, not proof of cause and effect.

Moan J, Lagunova Z, Bruland O, et al. Dermatoendocrinol, 2010. PMID 21547098

2009 / Cross-sectional study

Dietary intake of heterocyclic aromatic amines and consumption of fried and processed meat were linked to higher DNA adduct levels in female breast tissue.

Researchers assessed dietary meat and heterocyclic aromatic amine (HCA) intake via questionnaire in 44 women undergoing reduction mammoplasty and measured breast tissue DNA adduct levels using (32)P-postlabelling. Total HCA intake (r = 0.33, P = 0.03), fried meat (r = 0.39, P = 0.01), beef (r = 0.32, P = 0.03), and processed meat (r = 0.51, P = 0.0004) were significantly correlated with breast tissue DNA adduct levels. Detected adducts could not be confirmed as specific HCA-derived adducts, suggesting HCA intake may act as a surrogate for other genotoxic compounds like polycyclic aromatic hydrocarbons.

Shows an association, not proof of cause and effect.

Rohrmann S, Lukas Jung SU, Linseisen J, et al. Mutagenesis, 2009. PMID 18980957

2009 / Prospective cohort study

Whole grain intake was not associated with breast cancer risk in postmenopausal Danish women.

Researchers investigated whole grain intake and breast cancer risk across a mean follow-up of 9.6 years in 25,278 postmenopausal women from the Danish Diet, Cancer and Health cohort study, identifying 978 cases. A higher intake of whole grain products was not associated with breast cancer risk (adjusted IRR 1.01, 95% CI 0.96-1.07 per 50 g/day increment). Intakes of rye bread, oatmeal, and whole grain bread were also not associated with risk, nor were associations seen across ER/PR subtypes or tumor histology. Furthermore, no interaction was found between whole grain intake and hormone replacement therapy.

Shows an association, not proof of cause and effect.

Egeberg R, Olsen A, Loft S, et al. Int J Cancer, 2009. PMID 19004010

2009 / Case-control study

Higher dietary mushroom intake and its combination with green tea were linked to lower breast cancer risk in Chinese women.

A case-control study in southeast China assessed 1,009 incident breast cancer cases and 1,009 age-matched healthy controls to investigate the effects of mushroom and green tea consumption. Compared with nonconsumers, multivariate-adjusted odds ratios for breast cancer were 0.36 (95% CI: 0.25-0.51) for daily intake of >=10 g fresh mushrooms and 0.53 (95% CI: 0.38-0.73) for >=4 g dried mushrooms, with significant dose-response trends (p < 0.001) in both pre- and postmenopausal women. Compared with nonconsumers of both, ORs were 0.11 (95% CI: 0.06-0.20) for high fresh mushrooms plus >=1.05 g/day dried green tea leaves, and 0.18 (95% CI: 0.11-0.29) for high dried mushrooms plus green tea (trend p < 0.001).

Shows an association, not proof of cause and effect.

Zhang M, Huang J, Xie X, et al. Int J Cancer, 2009. PMID 19048616

2009 / Population-based case-control study

Consumption of cured/smoked meat and fish was linked to higher acute leukemia risk, while vegetables and bean-curd were linked to reduced risk in youth.

A population-based case-control study in southern Taiwan examined dietary habits in 145 acute leukemia cases and 370 matched controls aged 2 to 20 years. Consumption of cured/smoked meat and fish more than once a week was associated with an increased risk of acute leukemia (OR = 1.74; 95% CI: 1.15-2.64). Conversely, higher intake of vegetables (OR = 0.55; 95% CI: 0.37-0.83) and bean-curd (OR = 0.55; 95% CI: 0.34-0.89) was associated with a reduced risk. No statistically significant association was observed with consumption of pickled vegetables, fruits, or tea.

Shows an association, not proof of cause and effect.

Liu CY, Hsu YH, Wu MT, et al. BMC Cancer, 2009. PMID 19144145

2009 / Prospective cohort study

Higher intake of the soy isoflavone daidzein was linked to reduced breast cancer recurrence in postmenopausal women taking tamoxifen.

Researchers prospectively followed 1,954 female breast cancer survivors for 6.31 years, ascertaining 282 recurrences, to evaluate soy isoflavone intake assessed via food frequency questionnaires an average of 23 months post-diagnosis. Suggestive trends for reduced recurrence risk were seen with increasing quintiles of daidzein and glycetin intake among postmenopausal women (P for trend = 0.08 and 0.06, respectively) and tamoxifen users (P for trend = 0.10 and 0.05, respectively). Among postmenopausal women treated with tamoxifen, those in the highest versus lowest daidzein intake (>1,453 vs. <7.7 microg/day) had a reduced risk of breast cancer recurrence (HR 0.48; 95% CI, 0.21-0.79, P = 0.008).

Shows an association, not proof of cause and effect.

Guha N, Kwan ML, Quesenberry CP, et al. Breast Cancer Res Treat, 2009. PMID 19221874

2009 / Prospective cohort study

Grapefruit intake was not associated with breast cancer risk in a large prospective cohort of European women.

In the EPIC study, 114,504 women were followed for a median of 9.5 years, during which 3,747 incident breast cancers were identified. Fifty-nine percent reported eating grapefruit, and 4% consumed 60 g/day or more. Grapefruit intake was not related to breast cancer risk: compared to non-consumers, those with the highest intake (>=60 g/day) had a hazard ratio of 0.93 (95% CI 0.77-1.13; p for linear trend = 0.5). Subgroup analyses by menopausal status and hormone replacement therapy use also showed no relationship, nor was there an association with estradiol or estrone among postmenopausal women.

Shows an association, not proof of cause and effect.

Spencer EA, Key TJ, Appleby PN, et al. Cancer Causes Control, 2009. PMID 19224379

2009 / Hospital-based case-control study

Higher plasma levels of carotenoids, retinol, and tocopherols were linked to lower risk of ovarian cancer in Korean women.

A hospital-based case-control study in six tertiary medical institutes in Korea examined the relation between preoperative plasma carotenoids, retinol, and tocopherol levels and ovarian cancer risk. Compared to the lowest tertiles, women in the highest tertiles had significantly lower risk of ovarian cancer for beta-carotene (OR 0.12; 95% CI 0.04-0.36), lycopene (OR 0.09; 95% CI 0.03-0.32), zeaxanthin/lutein (OR 0.21; 95% CI 0.09-0.52), retinol (OR 0.45; 95% CI 0.21-0.98), alpha-tocopherol (OR 0.23; 95% CI 0.10-0.53), and gamma-tocopherol (OR 0.28; 95% CI 0.11-0.70). The authors concluded that these micronutrients may play a role in reducing ovarian cancer risk.

Shows an association, not proof of cause and effect.

Jeong NH, Song ES, Lee JM, et al. Acta Obstet Gynecol Scand, 2009. PMID 19266359

2009 / Population-based case-control study

Intake of certain sweets and lactose was linked to higher pancreatic cancer risk, primarily among men, but findings for sweets were inconsistent overall.

A population-based case-control study investigated associations between sweets, sweetened and unsweetened beverages, and sugars with pancreatic cancer risk in 532 cases and 1,701 controls. Among men, greater intakes of total sweets (OR = 1.9, 95% CI: 1.0, 3.6), sweet condiments (OR = 1.9, 95% CI: 1.2, 3.1), chocolate candy (OR = 2.4, 95% CI: 1.1, 5.0), and other mixed candy bars (OR = 3.3, 95% CI: 1.5, 7.3) for 1+ servings/day versus none/rarely were linked to increased risk, while sweets were not consistently associated with risk among women. Sweetened beverages were not associated with increased risk, but low-calorie soft drinks were associated with increased risk among men only. Among sugars, only lactose was associated with risk (OR = 2.0, 95% CI: 1.5, 2.7 comparing extreme quartiles).

Shows an association, not proof of cause and effect.

Chan JM, Wang F, Holly EA Cancer Causes Control, 2009. PMID 19277880

2009 / Prospective cohort study

Vegetarian diet was linked to lower overall cancer incidence but higher colorectal cancer incidence compared with meat eaters in the EPIC-Oxford cohort.

The EPIC-Oxford prospective study followed 63,550 men and women recruited throughout the UK to evaluate cancer incidence among vegetarians and nonvegetarians through nationwide registries. After adjusting for age, sex, and smoking, the incidence rate ratio for all malignant neoplasms was 0.89 (95% CI: 0.80, 1.00) in vegetarians compared with meat eaters. Conversely, the incidence rate ratio for colorectal cancer was 1.39 (95% CI: 1.01, 1.91) in vegetarians compared with meat eaters. Overall cancer incidence rates for both vegetarians and nonvegetarians in the study were low compared with national rates.

Shows an association, not proof of cause and effect.

Key TJ, Appleby PN, Spencer EA, et al. Am J Clin Nutr, 2009. PMID 19279082

2009 / Prospective cohort study

Both short and long sleep durations were linked to higher risks of cardiovascular and all-cause mortality compared to 7 hours of sleep in Japanese adults.

In the JACC study, 98,634 participants were followed for a median of 14.3 years to examine sex-specific associations between sleep duration and mortality. Compared with 7 hours of sleep, sleeping 4 hours or less was associated with higher all-cause mortality in men (HR 1.29, 95% CI 1.02-1.64) and women (HR 1.28, 95% CI 1.03-1.60), and higher coronary heart disease mortality in women (HR 2.32, 95% CI 1.19-4.50). Sleeping 10 hours or longer was associated with a 1.5- to 2-fold increased mortality from total and ischemic stroke, total cardiovascular disease, noncardiovascular/noncancer causes, and all causes in both sexes. Sleep duration was not associated with cancer mortality in either sex.

Shows an association, not proof of cause and effect.

Ikehara S, Iso H, Date C, et al. Sleep, 2009. PMID 19294949

2009 / Prospective cohort study

Higher red and processed meat intakes were linked to increased total, cancer, and cardiovascular disease mortality over 10 years of follow-up.

The NIH-AARP Diet and Health Study examined red, white, and processed meat intake assessed by food frequency questionnaire and followed half a million participants aged 50 to 71 years for 10 years, documenting 47,976 male and 23,276 female deaths. Highest vs lowest quintiles of red meat intake were associated with elevated total mortality in men (HR 1.31, 95% CI 1.27-1.35) and women (HR 1.36, 95% CI 1.30-1.43), as well as higher cancer and cardiovascular disease (CVD) mortality. Highest vs lowest processed meat intake was also associated with increased overall mortality (men: HR 1.16; women: HR 1.25), cancer mortality, and CVD mortality. In contrast, comparing the highest to lowest quintile of white meat intake showed an inverse association for total mortality, cancer mortality, and all other deaths in both men and women.

Shows an association, not proof of cause and effect.

Sinha R, Cross AJ, Graubard BI, et al. Arch Intern Med, 2009. PMID 19307518

2009 / Population-based case-control study

Higher childhood soy intake was linked to a lower risk of breast cancer in Asian American women.

A population-based case-control study evaluated soy intake during childhood, adolescence, and adulthood among 597 breast cancer cases and 966 controls of Chinese, Japanese, and Filipino descent aged 20 to 55 years. Mothers of 99 cases and 156 controls were interviewed regarding childhood exposures. Comparing the highest to lowest tertiles, multivariate relative risks were 0.40 (95% CI: 0.18-0.83; P trend = 0.03) for childhood soy intake, 0.80 (95% CI: 0.59-1.08; P trend = 0.12) for adolescent intake, and 0.76 (95% CI: 0.56-1.02; P trend = 0.04) for adult intake. The inverse association with childhood intake was consistent across all three ethnic groups, study sites, and birthplaces, and was not affected by adjustment for westernization measures.

Shows an association, not proof of cause and effect.

Korde LA, Wu AH, Fears T, et al. Cancer Epidemiol Biomarkers Prev, 2009. PMID 19318430

2009 / Comparative risk assessment modeling study

In 2005, smoking, high blood pressure, overweight-obesity, and poor diet were estimated to be major causes of death in US adults.

Using national health surveys and mortality statistics alongside effect estimates from systematic reviews, researchers estimated deaths attributable to 12 modifiable risk factors in the US in 2005. Smoking (467,000 deaths; 95% CI 436,000-500,000) and high blood pressure (395,000 deaths; 95% CI 372,000-414,000) were the leading causes. Overweight-obesity (216,000 deaths) and physical inactivity (191,000 deaths) each accounted for nearly 1 in 10 deaths. Among dietary factors, high dietary salt (102,000 deaths), low dietary omega-3 fatty acids (84,000 deaths), and high dietary trans fatty acids (82,000 deaths) had the largest estimated mortality effects.

Shows an association, not proof of cause and effect.

Danaei G, Ding EL, Mozaffarian D, et al. PLoS Med, 2009. PMID 19399161

2009 / Nested case-control study

Higher plasma choline and vitamin B2 levels were linked to increased prostate cancer risk, while methylmalonic acid was inversely linked.

Researchers examined plasma concentrations of seven one-carbon metabolism components in 561 prostate cancer cases and 1,034 matched controls nested within the Northern Sweden Health and Disease Cohort. Doubling of plasma concentrations was linked to higher prostate cancer risk for choline (RR 1.46, 95% CI 1.04-2.05, P trend = 0.03) and vitamin B2 (RR 1.11, 95% CI 1.00-1.23, P trend = 0.04). In contrast, doubling of methylmalonic acid (MMA) was linked to lower risk (RR 0.78, 95% CI 0.63-0.97, P trend = 0.03). Concentrations of betaine, cysteine, methionine, and vitamin B6 were not associated with prostate cancer risk.

Shows an association, not proof of cause and effect.

Johansson M, Van Guelpen B, Vollset SE, et al. Cancer Epidemiol Biomarkers Prev, 2009. PMID 19423531

2009 / Prospective cohort study

Diets higher in protein and cholesterol were linked to increased risk of cirrhosis or liver cancer, while higher carbohydrate intake was linked to lower risk.

Researchers analyzed 9,221 NHANES I participants aged 25-74 years followed for a mean of 13.3 years to evaluate dietary associations with cirrhosis or liver cancer death or hospitalization. Baseline diet was assessed via a 24-hour recall, and 123 participants subsequently developed cirrhosis (n = 118) or liver cancer (n = 5). Higher protein intake (P = 0.001) and cholesterol consumption (P = 0.007) were significantly associated with higher risk of cirrhosis or liver cancer, whereas higher carbohydrate intake was associated with lower risk (P = 0.003). Total fat consumption and serum cholesterol levels were not significantly associated with risk.

Shows an association, not proof of cause and effect.

Ioannou GN, Morrow OB, Connole ML, et al. Hepatology, 2009. PMID 19441103

2009 / Prospective cohort study

Being a fish eater or vegetarian was associated with a lower incidence of all malignant neoplasms compared to meat eaters in a British cohort.

A prospective study followed 61,566 British adults for an average of 12.2 years, identifying 3,350 incident cancers. Compared with meat eaters, relative risks (RRs) for all malignant neoplasms were 0.82 (95% CI: 0.73-0.93) in fish eaters and 0.88 (0.81-0.96) in vegetarians (P for heterogeneity = 0.001). Significant heterogeneity was observed across diet groups for stomach, ovarian, bladder, and lymphatic/haematopoietic cancers.

Shows an association, not proof of cause and effect.

NANO counterpoint →

Key TJ, Appleby PN, Spencer EA, et al. Br J Cancer, 2009. PMID 19536095

2009 / Pooled nested case-control study

Current cigarette smoking, higher intensity, and longer duration were linked to an increased risk of pancreatic cancer in a pooled analysis.

Researchers analyzed pooled data from the Pancreatic Cancer Cohort Consortium nested case-control study including 1,481 cases and 1,539 controls. Compared with never smokers, current smokers had an elevated risk of pancreatic cancer (OR = 1.77, 95% CI: 1.38, 2.26). Risk increased significantly with smoking intensity of 30 or more cigarettes/day (OR = 1.75, 95% CI: 1.27, 2.42), duration of 50 or more years (OR = 2.13, 95% CI: 1.25, 3.62), and cumulative dose of 40 or more pack-years (OR = 1.78, 95% CI: 1.35, 2.34). Risk more than 15 years after smoking cessation was similar to that for never smokers.

Shows an association, not proof of cause and effect.

Lynch SM, Vrieling A, Lubin JH, et al. Am J Epidemiol, 2009. PMID 19561064

2009 / Prospective cohort study

Higher intakes of total, saturated, and monounsaturated fats—particularly animal-derived saturated fat—were linked to increased pancreatic cancer risk.

In the NIH-AARP Diet and Health Study, 525,473 men and women were followed for an average of 6.3 years, during which 865 men and 472 women were diagnosed with exocrine pancreatic cancer. After multivariable adjustment, pancreatic cancer risk was directly related to intakes of total fat (highest vs lowest quintile HR = 1.23, 95% CI = 1.03 to 1.46), saturated fat (HR = 1.36, 95% CI = 1.14 to 1.62), and monounsaturated fat (HR = 1.22, 95% CI = 1.02 to 1.46), but not polyunsaturated fat. The strongest association was observed for saturated fat from animal food sources (HR = 1.43, 95% CI = 1.20 to 1.70), with saturated fat intakes from red meat (HR = 1.27) and dairy products (HR = 1.19) both significantly associated with increased risk.

Shows an association, not proof of cause and effect.

Thiébaut AC, Jiao L, Silverman DT, et al. J Natl Cancer Inst, 2009. PMID 19561318

2009 / Retrospective cohort study

In 8,541 cancer patients, cachexia prevalence varied from 2.4% to 14.7% depending on the clinical definition used.

Electronic medical records were examined to estimate the proportion of patients with select cancers who developed cachexia based on four separate clinical definitions. Among 8,541 cancer patients, cachexia was identified in 2.4% using the ICD-9 cachexia code, 5.5% using expanded diagnoses, 6.4% using prescription medication records, and 14.7% using a criterion of >=5% weight loss. The authors conclude that the proportion of patients with cachexia varied considerably depending on the definition employed, highlighting the need for a standard operational definition.

Shows an association, not proof of cause and effect.

Fox KM, Brooks JM, Gandra SR, et al. J Oncol, 2009. PMID 19587829